The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Circulating Tumor Cells (CTC) Market Research Report 2024
Synopsis
Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.
The global Circulating Tumor Cells (CTC) market was valued at US$ 1584.6 million in 2023 and is anticipated to reach US$ 4297.5 million by 2030, witnessing a CAGR of 15.0% during the forecast period 2024-2030.
Global Circulating Tumor Cells main players are Menarini-Silicon Biosystems, Qiagen（Adnagen）, Clearbridge Biomedics, Celsee, Fluidigm. Global top five manufacturers hold a share over 30%.
This report aims to provide a comprehensive presentation of the global market for Circulating Tumor Cells (CTC), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Circulating Tumor Cells (CTC).
Report Scope
The Circulating Tumor Cells (CTC) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Circulating Tumor Cells (CTC) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Circulating Tumor Cells (CTC) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AdnaGen
Apocell
Biocep
Canopus Bioscience
Creatv Microtech
Ikonisys
IV Diagnostics
Miltenyi Biotech
Nanostring Technologies
Rarecells Diagnostics
Vitatex
Segment by Type
Ex-Vivo Positive Selection
In-Vivo Positive Selection
Negative Selection
Microchips & Single Spiral Micro Channel
Segment by Application
Tumorigenesis Research
Emt Biomarkers Development
Cancer Stem Cell Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Circulating Tumor Cells (CTC) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.
The global Circulating Tumor Cells (CTC) market was valued at US$ 1584.6 million in 2023 and is anticipated to reach US$ 4297.5 million by 2030, witnessing a CAGR of 15.0% during the forecast period 2024-2030.
Global Circulating Tumor Cells main players are Menarini-Silicon Biosystems, Qiagen（Adnagen）, Clearbridge Biomedics, Celsee, Fluidigm. Global top five manufacturers hold a share over 30%.
This report aims to provide a comprehensive presentation of the global market for Circulating Tumor Cells (CTC), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Circulating Tumor Cells (CTC).
Report Scope
The Circulating Tumor Cells (CTC) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Circulating Tumor Cells (CTC) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Circulating Tumor Cells (CTC) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AdnaGen
Apocell
Biocep
Canopus Bioscience
Creatv Microtech
Ikonisys
IV Diagnostics
Miltenyi Biotech
Nanostring Technologies
Rarecells Diagnostics
Vitatex
Segment by Type
Ex-Vivo Positive Selection
In-Vivo Positive Selection
Negative Selection
Microchips & Single Spiral Micro Channel
Segment by Application
Tumorigenesis Research
Emt Biomarkers Development
Cancer Stem Cell Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Circulating Tumor Cells (CTC) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Tumor Cells (CTC) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Ex-Vivo Positive Selection
1.2.3 In-Vivo Positive Selection
1.2.4 Negative Selection
1.2.5 Microchips & Single Spiral Micro Channel
1.3 Market by Application
1.3.1 Global Circulating Tumor Cells (CTC) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Tumorigenesis Research
1.3.3 Emt Biomarkers Development
1.3.4 Cancer Stem Cell Research
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Circulating Tumor Cells (CTC) Market Perspective (2019-2030)
2.2 Circulating Tumor Cells (CTC) Growth Trends by Region
2.2.1 Global Circulating Tumor Cells (CTC) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Circulating Tumor Cells (CTC) Historic Market Size by Region (2019-2024)
2.2.3 Circulating Tumor Cells (CTC) Forecasted Market Size by Region (2025-2030)
2.3 Circulating Tumor Cells (CTC) Market Dynamics
2.3.1 Circulating Tumor Cells (CTC) Industry Trends
2.3.2 Circulating Tumor Cells (CTC) Market Drivers
2.3.3 Circulating Tumor Cells (CTC) Market Challenges
2.3.4 Circulating Tumor Cells (CTC) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cells (CTC) Players by Revenue
3.1.1 Global Top Circulating Tumor Cells (CTC) Players by Revenue (2019-2024)
3.1.2 Global Circulating Tumor Cells (CTC) Revenue Market Share by Players (2019-2024)
3.2 Global Circulating Tumor Cells (CTC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Circulating Tumor Cells (CTC) Revenue
3.4 Global Circulating Tumor Cells (CTC) Market Concentration Ratio
3.4.1 Global Circulating Tumor Cells (CTC) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cells (CTC) Revenue in 2023
3.5 Circulating Tumor Cells (CTC) Key Players Head office and Area Served
3.6 Key Players Circulating Tumor Cells (CTC) Product Solution and Service
3.7 Date of Enter into Circulating Tumor Cells (CTC) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Circulating Tumor Cells (CTC) Breakdown Data by Type
4.1 Global Circulating Tumor Cells (CTC) Historic Market Size by Type (2019-2024)
4.2 Global Circulating Tumor Cells (CTC) Forecasted Market Size by Type (2025-2030)
5 Circulating Tumor Cells (CTC) Breakdown Data by Application
5.1 Global Circulating Tumor Cells (CTC) Historic Market Size by Application (2019-2024)
5.2 Global Circulating Tumor Cells (CTC) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Circulating Tumor Cells (CTC) Market Size (2019-2030)
6.2 North America Circulating Tumor Cells (CTC) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Circulating Tumor Cells (CTC) Market Size by Country (2019-2024)
6.4 North America Circulating Tumor Cells (CTC) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Circulating Tumor Cells (CTC) Market Size (2019-2030)
7.2 Europe Circulating Tumor Cells (CTC) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Circulating Tumor Cells (CTC) Market Size by Country (2019-2024)
7.4 Europe Circulating Tumor Cells (CTC) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Circulating Tumor Cells (CTC) Market Size (2019-2030)
8.2 Asia-Pacific Circulating Tumor Cells (CTC) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region (2019-2024)
8.4 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Circulating Tumor Cells (CTC) Market Size (2019-2030)
9.2 Latin America Circulating Tumor Cells (CTC) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Circulating Tumor Cells (CTC) Market Size by Country (2019-2024)
9.4 Latin America Circulating Tumor Cells (CTC) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Circulating Tumor Cells (CTC) Market Size (2019-2030)
10.2 Middle East & Africa Circulating Tumor Cells (CTC) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country (2019-2024)
10.4 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AdnaGen
11.1.1 AdnaGen Company Detail
11.1.2 AdnaGen Business Overview
11.1.3 AdnaGen Circulating Tumor Cells (CTC) Introduction
11.1.4 AdnaGen Revenue in Circulating Tumor Cells (CTC) Business (2019-2024)
11.1.5 AdnaGen Recent Development
11.2 Apocell
11.2.1 Apocell Company Detail
11.2.2 Apocell Business Overview
11.2.3 Apocell Circulating Tumor Cells (CTC) Introduction
11.2.4 Apocell Revenue in Circulating Tumor Cells (CTC) Business (2019-2024)
11.2.5 Apocell Recent Development
11.3 Biocep
11.3.1 Biocep Company Detail
11.3.2 Biocep Business Overview
11.3.3 Biocep Circulating Tumor Cells (CTC) Introduction
11.3.4 Biocep Revenue in Circulating Tumor Cells (CTC) Business (2019-2024)
11.3.5 Biocep Recent Development
11.4 Canopus Bioscience
11.4.1 Canopus Bioscience Company Detail
11.4.2 Canopus Bioscience Business Overview
11.4.3 Canopus Bioscience Circulating Tumor Cells (CTC) Introduction
11.4.4 Canopus Bioscience Revenue in Circulating Tumor Cells (CTC) Business (2019-2024)
11.4.5 Canopus Bioscience Recent Development
11.5 Creatv Microtech
11.5.1 Creatv Microtech Company Detail
11.5.2 Creatv Microtech Business Overview
11.5.3 Creatv Microtech Circulating Tumor Cells (CTC) Introduction
11.5.4 Creatv Microtech Revenue in Circulating Tumor Cells (CTC) Business (2019-2024)
11.5.5 Creatv Microtech Recent Development
11.6 Ikonisys
11.6.1 Ikonisys Company Detail
11.6.2 Ikonisys Business Overview
11.6.3 Ikonisys Circulating Tumor Cells (CTC) Introduction
11.6.4 Ikonisys Revenue in Circulating Tumor Cells (CTC) Business (2019-2024)
11.6.5 Ikonisys Recent Development
11.7 IV Diagnostics
11.7.1 IV Diagnostics Company Detail
11.7.2 IV Diagnostics Business Overview
11.7.3 IV Diagnostics Circulating Tumor Cells (CTC) Introduction
11.7.4 IV Diagnostics Revenue in Circulating Tumor Cells (CTC) Business (2019-2024)
11.7.5 IV Diagnostics Recent Development
11.8 Miltenyi Biotech
11.8.1 Miltenyi Biotech Company Detail
11.8.2 Miltenyi Biotech Business Overview
11.8.3 Miltenyi Biotech Circulating Tumor Cells (CTC) Introduction
11.8.4 Miltenyi Biotech Revenue in Circulating Tumor Cells (CTC) Business (2019-2024)
11.8.5 Miltenyi Biotech Recent Development
11.9 Nanostring Technologies
11.9.1 Nanostring Technologies Company Detail
11.9.2 Nanostring Technologies Business Overview
11.9.3 Nanostring Technologies Circulating Tumor Cells (CTC) Introduction
11.9.4 Nanostring Technologies Revenue in Circulating Tumor Cells (CTC) Business (2019-2024)
11.9.5 Nanostring Technologies Recent Development
11.10 Rarecells Diagnostics
11.10.1 Rarecells Diagnostics Company Detail
11.10.2 Rarecells Diagnostics Business Overview
11.10.3 Rarecells Diagnostics Circulating Tumor Cells (CTC) Introduction
11.10.4 Rarecells Diagnostics Revenue in Circulating Tumor Cells (CTC) Business (2019-2024)
11.10.5 Rarecells Diagnostics Recent Development
11.11 Vitatex
11.11.1 Vitatex Company Detail
11.11.2 Vitatex Business Overview
11.11.3 Vitatex Circulating Tumor Cells (CTC) Introduction
11.11.4 Vitatex Revenue in Circulating Tumor Cells (CTC) Business (2019-2024)
11.11.5 Vitatex Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
